Cognition Therapeutics Q3 EPS $(0.04) Beats $(0.07) Estimate
Benzinga Newsdesk 2 days ago
NewsEarningsEarnings Beats
Cognition Therapeutics (NASDAQ:CGTX) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.07) by 42.86 percent. This is a 33.33 percent increase over losses of $(0.06) per
Cognition Therapeutics (NASDAQ:CGTX) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.07) by 42.86 percent. This is a 33.33 percent increase over losses of $(0.06) per share from the same period last year.